Comparison of Plasma Virus Loads among Individuals Infected with Hepatitis C Virus (HCV) Genotypes 1, 2, and 3 by Quantiplex HCV RNA Assay Versions 1 and 2, Roche Monitor Assay, and an In-House Limiting Dilution Method

Journal of Clinical Microbiology

Volumn 35, Issue 1, 1997, Pages 187-192

  Hawkins, A ^a   Davidson, F ^b   Simmonds, P ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Edinburgh S E Scotland Blood T   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DILUTION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS CONCENTRATION;

GENES, VIRAL; HEPACIVIRUS; HEPATITIS C; HUMANS; RNA, VIRAL; VIRAL LOAD;

CHIRON; HEPATITIS C VIRUS;

EID: 0031059943     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.1.187-192.1997     Document Type: Review

References (30)

1. Arase, Y., H. Kumada, K. Chayama, M. Naoya, A. Tsubota, I. Koida, M. Kobayashi, Y. Suzuki, K. Ikeda, and S. Saitoh. 1995. Usefulness of HCV-RNA counts by the method of HCV-bDNA probe in interferon retreatment for patients with HCV-RNA positive chronic hepatitis C. Int. Hepatol. Commun. 4:19-25.
2. Berger, A., M. vonDepkaProndzinski, H. W. Doerr, H. Rabenau, and B. Weber. 1996. Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection. J. Med. Virol. 48:339-343.
3. Chan, C. Y., S. D. Lee, S. J. Hwang, R. H. Lu, C. L. Lu, and K. J. Lo. 1995. Quantitative branched DNA assay and genotyping for hepatitis C virus RNA in Chinese patients with acute and chronic hepatitis C. J. Infect. Dis. 171: 443-446.
4. Chan, S.-W., F. McOmish, E. C. Holmes, B. Dow, J. F. Peutherer, E. Follett, P. L. Yap, and P. Simmonds. 1992. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J. Gen. Virol. 73:1131-1141.
5. Collins, M. L., C. Zayati, J. J. Detmer, B. Daly, J. A. Kolberg, T. A. Cha, B. D. Irvine, J. Tucker, and M. S. Urdea. 1995. Preparation and characterization of RNA standards for use in quantitative branced DNA hybridization assays. Anal. Biochem. 226:120-129.
6. Daly, J. A., and G. Ertingshausen. 1972. Direct method for determining inorganic phosphate in serum with the "CentrifiChem." Clin. Chem. 18:263-265.
7. Davidson, F., P. Simmonds, J. C. Ferguson, L. M. Jarvis, B. C. Dow, E. A. C. Follett, C. R. G. Seed, T. Krusius, C. Lin, G. A. Medgyesi, H. Kiyokawa, G. Olim, G. Duraisamy, T. Cuypers, A. A. Saeed, D. Teo, J. Conradie, M. C. Kew, M. Lin, C. Nuchaprayoon, O. K. Ndimbie, and P. L. Yap. 1995. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J. Gen. Virol. 76:1197-1204.
8. Davis, G. L. 1994. Prediction of response to interferon treatment of chronic hepatitis C. J. Hepatol. 21:1-3.
9. Detmer, J., R. Lagier, J. Flynn, C. Zayati, J. Kolberg, M. Collins, M. Urdea, and R. Sanchez-Pescador. 1996. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J. Clin. Microbiol. 34:901-907.
10. Hayashi, J., Y. Kishihara, E. Yoshimura, Y. Tani, K. Yamaji, H. Ikematsu, H. Ishiko, and S. Kashiwagi. 1995. Relationship of genotype to level of hepatitis C viraemia determined by competitive polymerase chain reaction. J. Infect. 30:235-239.
11. Jarvis, L. M., C. A. Ludlam, J. A. Ellender, L. Nemes, S. P. Field, E. Song, A. Chuansumrit, F. E. Preston, and P. Simmonds. 1996. Investigation of the relative infectivity and pathogenicity of different hepatitis C virus genotypes in hemophiliacs. Blood 87:3007-3011.
12. Lau, J. Y. N., G. L. Davis, J. Kniffen, K. P. Qian, M. S. Urdea, C. S. Chan, M. Mizokami, P. D. Neuwald, and J. C. Wilber. 1993. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341:1501-1504.
13. Lau, J. Y. N., G. L. Davis, L. E. Prescott, G. Maertens, K. L. Lindsay, K. P. Qian, M. Mizokami, P. Simmonds, R. P. Perrillo, E. R. Schiff, H. C. Bodenheimer, L. A. Balart, F. Regenstein, J. L. Dienstag, W. N. Katkov, C. H. Tamburro, J. S. Goff, G. T. Everson, Z. Goodman, and J. Albrecht. 1996. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Ann. Intern. Med. 124:868.
14. Lau, J. Y. N., P. Simmonds, and M. S. Urdea. 1995. Implications of variations of "conserved" regions of hepatitis C virus genome. Lancet 346:425-426.
15. Mahaney, K., V. Tedeschi, G. Maertens, A. M. Dibisceglie, J. Vergalla, J. H. Hoofnagle, and R. Sallie. 1994. Genotypic analysis of hepatitis C virus in American patients. Hepatology 20:1405-1411.
16. Martinot Peignoux, M., P. Marcellin, M. Pouteau, C. Castelnau, N. Boyer, M. Poliquin, C. Degott, I. Descombes, V. Lebreton, V. Milotova, J. P. Benhamou, and S. Erlinger. 1995. Pretreatment serum hapatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 22:1050-1056.
17. Matsumoto, A., E. Tanaka, T. Suzuki, H. Ogata, and K. Koyosawa. 1994. Viral and host factors that contribute to efficacy of interferon-alpha(2a) therapy in patients with chronic hapatitis C. Dig. Dis. Sci. 39:1273-1280.
18. McOmish, F., S.-W. Chan, B. C. Dow, J. Gillon, W. D. Frame, R. J. Crawford, P. L. Yap, E. A. C. Follett, and P. Simmonds. 1993. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serological reactivity and rate of alanine aminotransferase abnormalities. Transfusion 33:7-13.
19. Mita, E., N. Hayashi, H. Hagiwara, K. Ueda, Y. Kanazawa, A. Kasahara, H. Fusamoto, and T. Kamada. 1994. Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Dig. Dis. Sci. 39:977-982.
20. Mizokami, M., E. Orito, Y. Gibo, K. Suzuki, K. Ohba, T. Ohno, and J. Y. N. Lau. 1996. Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C. Liver 16:23-27.
21. Nousbaum, J. B., S. Pol, B. Nalpas, P. Landais, P. Berthelot, C. Brechot, M. Gigou, C. Feray, V. Thiers, H. Okamoto, S. Mishiro, K. Poussin, P. Paterlini, M. Rumi, and M. Colombo. 1995. Hepatitis C virus type 1b (II) infection in France and Italy. Ann. Intern. Med. 122:161.
22. Orito, E., M. Mizokami, T. Nakano, H. Terashima, O. Nojiri, H. Sakakibara, M. Mizuno, M. Ogino, M. Nakamura, Y. Matsumoto, K. I. Miyata, and J. Y. N. Lan. 1994. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C. J. Med. Virol. 44:410-414.
23. Simmonds, P., P. Balfe, J. F. Peutherer, C. A. Ludlam, J. O. Bishop, and A. J. L. Brown. 1990. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J. Virol. 64:864-872.
24. Simmonds, P., L. Q. Zhang, H. G. Watson, S. Rebus, E. D. Ferguson, P. Balfe, G. H. Leadbetter, P. L. Yap, J. F. Peutherer, and C. A. Ludlam. 1990. Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. Lancet 336:1469-1472.
25. Smith, D. B., F. Davidson, P. L. Yap, H. Brown, J. Kolberg, J. Detmer, M. Urdea, P. Simmonds, J. Mellor, J. Neville, L. Prescott, B. C. Dow, E. A. C. Follett, T. Skuldamrongpanich, S. Tanprasert, C. Nuchaprayoon, C. K. Lin, M. C. Kew, R. Crookes, J. D. Conradie, M. Lin, C. Seed, G. A. B. Deolim, I. A. Martins, G. A. Medgyesi, T. Krusius, A. A. Saeed, D. Teo, and S. H. Lee. 1996. Levels of hepatitis C virus in blood donors infected with different viral genotypes. J. Infect. Dis. 173:727-730.
26. Smith, D. B., J. Mellor, L. M. Jarvis, F. Davidson, J. Kolberg, M. Urdea, P. L. Yap, P. Simmonds, J. D. Conradie, A. G. S. Neill, G. M. Dusheiko, M. C. Kew, R. Crookes, A. Koshy, C. K. Lin, C. Lai, I. M. Murraylyon, A. Elguneid, A. A. Gunaid, T. Yemen, S. Yemen, D. Mutimer, M. Ahmed, C. Nuchprayoon, S. Tanprasert, F. E. Preston, M. Makris, A. Chuansumrit, C. Mahasandana, D. Pritchard, E. Riley, B. M. Greenwood, A. A. Saeed, A. M. Alrasheed, M. G. Saleh, I. Mcfarlane, C. Tibbs, R. Williams, J. Power, E. Lawlor, and H. Kiyokawa. 1995. Variation of the hepatitis C virus 5′ noncoding region: implications for secondary structure, virus detection and typing. J. Gen. Virol. 76:1749-1761.
27. Warshaw, M. M., and I. Tinico. 1996. Optical properties of sixteen dinucleoside phosphates. J. Mol. Biol. 20:29-38.
28. Yamada, G., R. Takatani, F. Kishi, M. Takahashi, T. Doi, T. Tsuji, S. Shin, M. Tanno, M. S. Urdea, and J. A. Kolberg. 1995. Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level. Hepatology 22:1351-1354.
29. Young, K. K. Y., R. M. Resnick, and T. W. Myers. 1993. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J. Clin. Microbiol. 31:882-886.
30. Zhang, L. Q., P. Simmonds, C. A. Ludlam, and A. J. Leigh Brown. 1991. Detection, quantitation and sequencing of HIV-1 virus from the plasma of seropositive individuals and from factor VIII concentrates. AIDS 5:675-681.